Level of Unawareness and Management of Diabetes, Hypertension, and Dyslipidemia among Adults in Luxembourg: Findings from ORISCAV-LUX Study

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Alkerwi, Ala'a ^a   Pagny, Sybil ^a   Lair, Marie Lise ^a   Delagardelle, Charles ^b   Beissel, Jean ^b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AWARENESS; BODY MASS; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; FRAMINGHAM RISK SCORE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; LUXEMBOURG; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PREVALENCE;

ADOLESCENT; ADULT; AGED; CORONARY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; LUXEMBOURG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84874630553     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057920     Document Type: Article

References (26)

1. Ministry of Health (2010) National Statistics of all causes of death, Statistiques des causes de décès. Luxembourg: Ministère de la Santé, Statistiques des causes de décès. Accessed on URL:http://www.sante.public.lu/fr/maladies-traitements/070-statistiques-causes-deces/index.html.
2. Tchicaya A, Braun M, Lorentz N, Delagardelle C, Beissel J,et al. (2012) Social inequality in awareness of cardiovascular risk factors in patients undergoing coronary angiography. Eur J Prev Cardiol.
3. Alkerwi A, Sauvageot N, Donneau AF, Lair ML, Couffignal S, et al. (2010) First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX). BMC Public Health 10: 468.
4. Alkerwi A, Sauvageot N, Couffignal S, Albert A, Lair ML, et al. (2010) Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg. BMC Med Res Methodol 10: 80.
5. El Assaad MA, Topouchian JA, Darne BM, Asmar RG, (2002) Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit 7: 237-241.
6. Verberk WJ, Kroon AA, Kessels AG, Lenders JW, Thien T, et al. (2006) The optimal scheme of self blood pressure measurement as determined from ambulatory blood pressure recordings. J Hypertens 24: 1541-1548.
7. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, et al. (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28: 88-136.
8. The International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327-1334.
9. American Diabetes Association, (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32Suppl 1: S62-67.
10. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105-1187.
11. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24: 1601-1610.
12. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847.
13. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, et al. (2004) Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43: 10-17.
14. Aguado A, Lopez F, Miravet S, Oriol P, Fuentes MI, et al. (2009) Hypertension in the very old; prevalence, awareness, treatment and control: a cross-sectional population-based study in a Spanish municipality. BMC Geriatr 9: 16.
15. Danon-Hersch N, Marques-Vidal P, Bovet P, Chiolero A, Paccaud F, et al. (2009) Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil 16: 66-72.
16. Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, et al. (2005) Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. J Hypertens 23: 1661-1666.
17. McDonald M, Hertz RP, Unger AN, Lustik MB, (2009) Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. Journals of Gerontology Series A, Biological Sciences and Medical Sciences 64: 256-263.
18. Costanzo S, Di Castelnuovo A, Zito F, Krogh V, Siani A, et al. (2008) Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary habit profile in European communities with different risk of myocardial infarction-the impact of migration as a model of gene-environment interaction project. J Hypertens 26: 2303-2311.
19. Hyman DJ, Pavlik VN, (2001) Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 345: 479-486.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
21. Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, et al. (2007) Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 25: 1491-1498.
22. Thoenes M, Bramlage P, Zhong S, Shang S, Volpe M, et al. (2012) Hypertension control and cardiometabolic risk: a regional perspective. Cardiol Res Pract 2012: 925046.
23. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, et al. (2004) Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol 33: 1345-1352.
24. Cai L, Zhang L, Liu A, Li S, Wang P, (2012) Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China. J Atheroscler Thromb 19: 159-168.
25. Wang S, Xu L, Jonas JB, You QS, Wang YX, et al. (2011) Prevalence and associated factors of dyslipidemia in the adult Chinese population. PLoS One 6: e17326.
26. Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, et al. (2006) Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113: 647-656.